Impact of patient's specification on clinical outcome for an I-131 ablation therapy with differentiated thyroid carcinoma.

被引：0
|
作者：
Nakayama, M. [1 ]
Okizaki, A. [1 ]
Sakaguchi, M. [2 ]
Uno, T. [2 ]
Sato, J. [2 ]
Ishitoya, S. [1 ]
机构：
[1] Asahikawa Med Univ, Dept Radiol, Asahikawa, Hokkaido, Japan
[2] Asahikawa Med Univ Hosp, Radiol Technol Sect, Asahikawa, Hokkaido, Japan
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2013年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S353 / S353
页数：1
相关论文
共 50 条
  • [21] Adjuvant thyroid remnant ablation in patients with differentiated thyroid carcinoma confined to the thyroid: a comparison of ablation success with different activities of radioiodine (I-131)
    Prpic, Marin
    Dabelic, Nina
    Stanicic, Josip
    Jukic, Tomislav
    Milosevic, Milan
    Kusic, Zvonko
    ANNALS OF NUCLEAR MEDICINE, 2012, 26 (09) : 744 - 751
  • [22] Adjuvant thyroid remnant ablation in patients with differentiated thyroid carcinoma confined to the thyroid: a comparison of ablation success with different activities of radioiodine (I-131)
    Marin Prpic
    Nina Dabelic
    Josip Stanicic
    Tomislav Jukic
    Milan Milosevic
    Zvonko Kusic
    Annals of Nuclear Medicine, 2012, 26 : 744 - 751
  • [23] Contribution of I-131 SPECT/CT on Staging of Differentiated Thyroid Carcinoma
    De Bonilla Damia, A.
    Cambil Molina, T.
    Calvo Moron, M.
    De la Riva Perez, P.
    Borbon Arce, M.
    Castro Montano, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S448 - S448
  • [24] INADEQUACY OF MODERATE DOSE OF I-131 FOR ABLATION OF THYROID REMNANTS FOLLOWING SURGERY FOR DIFFERENTIATED THYROID-CARCINOMA (DTC)
    SIDDIQUI, AR
    EDMONDSON, J
    WELLMAN, HN
    PARK, HM
    SCHNUTE, R
    JOHNSTON, CC
    JOURNAL OF NUCLEAR MEDICINE, 1980, 21 (06) : P30 - P30
  • [25] Acute Hematologic Consequences of High-Dose I-131 Therapy for Aggressive Thyroid Carcinoma.
    Lagrew, J. E.
    Bush, H. M.
    Ain, K. B.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [26] ASSESSMENT OF FEMALE FERTILITY AND CARCINOGENESIS AFTER I-131 THERAPY FOR DIFFERENTIATED THYROID-CARCINOMA
    DOTTORINI, ME
    LOMUSCIO, G
    MAZZUCCHELLI, L
    VIGNATI, A
    COLOMBO, L
    JOURNAL OF NUCLEAR MEDICINE, 1995, 36 (01) : 21 - 27
  • [27] I-131 THERAPY IN DIFFERENTIATED THYROID-CARCINOMA - MD-ANDERSON-HOSPITAL EXPERIENCE
    MAHESHWARI, YK
    HILL, CS
    HAYNIE, TP
    HICKEY, RC
    SAMAAN, NA
    CANCER, 1981, 47 (04) : 664 - 671
  • [28] DIURETIC-ENHANCED I-131 CLEARANCE AFTER ABLATION THERAPY FOR DIFFERENTIATED THYROID-CANCER
    SEABOLD, JE
    BENHAIM, S
    PETTIT, WA
    GURLI, NJ
    ROJESKI, MT
    FLANIGAN, MJ
    PONTO, JA
    BRICKER, JA
    RADIOLOGY, 1993, 187 (03) : 839 - 842
  • [29] Clinical applications of SPECT/CT after first I-131 ablation in patients with differentiated thyroid cancer
    Jeong, Shin Young
    Lee, Sang-Woo
    Kim, Hae Won
    Song, Bong-Il
    Ahn, Byeong-Cheol
    Lee, Jaetae
    CLINICAL ENDOCRINOLOGY, 2014, 81 (03) : 445 - 451
  • [30] The influence of I-131 therapy on FDG uptake in differentiated thyroid cancer
    Hung, Guang-Uei
    Lee, Kwo-Whei
    Liao, Pei-Yung
    Yang, Li-Heng
    Yang, Kwang-Tao
    ANNALS OF NUCLEAR MEDICINE, 2008, 22 (06) : 481 - 485
12345